Therefore, we cannot rule out that the high liver B1R expression observed in COVID-19 could be triggered not just by the systemic effect of SARS-CoV-2 infection but also by hydroxychloroquine taken by some patients in the current study (Santana et al., 2021). The gene discussed is BDKRB1; the disease is COVID-19.